Clinical Trial Detail

NCT ID NCT03739801
Title MM-398 and Ramucirumab in Treating Patients With Gastric Cancer or Gastroesophageal Junction Adenocarcinoma
Recruitment Withdrawn
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors University of Southern California
Indications

gastric adenocarcinoma

gastroesophageal junction adenocarcinoma

Therapies

MM-398 + Ramucirumab

Age Groups: adult senior

No variant requirements are available.